XML 48 R36.htm IDEA: XBRL DOCUMENT v3.25.3

Reportable Segments (Tables)

9 Months Ended

Sep. 30, 2025

Segment Reporting [Abstract]

Reportable Segment Financial Information

The Company identifies its operating segments for segment reporting purposes primarily on the basis of product type, production processes, distribution methods and management organizations.

Reportable Segment Financial Information (in thousands):

			Three Months Ended September 30, 2025
			EMG						EIG						Corporate						Total Consolidated
Net Sales			$	646,309					$	1,246,332					$	—					$	1,892,641
Cost of sales (1)			460,061						746,444						—						1,206,505
Selling expense			22,373						147,451						—						169,824
Segment Operating Income			163,875						352,437						—						516,312
Corporate G&A			—						—						27,932						27,932
Operating Income			163,875						352,437						(27,932)						488,380
Interest expense			—						—						(22,514)						(22,514)
Other (expense) income, net (2)			—						—						(17,901)						(17,901)
Income before Income Taxes			$	163,875					$	352,437					$	(68,347)					$	447,965
Depreciation			14,964						19,409						1,407						35,780
Amortization			18,711						48,587						—						67,298
Total depreciation and amortization			$	33,675					$	67,996					$	1,407					$	103,078
Research, Development & Engineering costs (3)			$	19,995					$	74,686					$	—					$	94,681
Assets			$	4,837,524					$	10,717,580					$	627,153					$	16,182,257
Capital Expenditures (4)			$	7,929					$	12,984					$	—					$	20,913

(1)Includes $7.8 million of acquisition-related costs.

(2)Includes $12.0 million of acquisition-related costs.

(3)Included in cost of sales.

(4)Excludes $23.1 million of acquired capital expenditures in EIG.

			Three Months Ended September 30, 2024
			EMG						EIG						Corporate						Total Consolidated
Net Sales			$	573,976					$	1,134,588					$	—					$	1,708,564
Cost of sales			420,375						672,379						—						1,092,754
Selling expense			22,082						123,246						—						145,328
Segment Operating Income			131,519						338,963						—						470,482
Corporate G&A			—						—						24,631						24,631
Operating Income			131,519						338,963						(24,631)						445,851
Interest expense			—						—						(25,118)						(25,118)
Other (expense) income, net			—						—						(1,888)						(1,888)
Income before Income Taxes			$	131,519					$	338,963					$	(51,637)					$	418,845
Depreciation			$	12,120					$	17,123					$	1,303					$	30,546
Amortization			16,716						43,105						—						59,821
Total depreciation and amortization			$	28,836					$	60,228					$	1,303					$	90,367
Research, Development & Engineering costs (1)			$	17,692					$	76,623					$	—					$	94,315
Assets			$	4,850,224					$	9,384,031					$	533,384					$	14,767,639
Capital Expenditures			$	9,073					$	13,622					$	3,587					$	26,282

(1)Included in cost of sales.

			Nine Months Ended September 30, 2025
			EMG						EIG						Corporate						Total Consolidated
Net Sales			$	1,853,092					$	3,549,576					$	—					$	5,402,668
Cost of sales (1)			1,349,981						2,105,662						—						3,455,643
Selling expense			66,630						392,999						—						459,629
Segment Operating Income			436,481						1,050,915						—						1,487,396
Corporate G&A			—						—						82,561						82,561
Operating Income			436,481						1,050,915						(82,561)						1,404,835
Interest expense			—						—						(58,364)						(58,364)
Other (expense) income, net (2)			—						—						(22,115)						(22,115)
Income before Income Taxes			$	436,481					$	1,050,915					$	(163,040)					$	1,324,356
Depreciation			$	46,022					$	57,296					$	4,324					$	107,642
Amortization			72,166						137,338						—						209,504
Total depreciation and amortization			$	118,188					$	194,634					$	4,324					$	317,146
Research, Development & Engineering costs (3)			$	62,270					$	221,503					$	—					$	283,773
Capital Expenditures (4)			$	25,286					$	34,653					$	13,312					$	73,251

(1)Includes $7.8 million of acquisition-related costs.

(2)Includes $12.0 million of acquisition-related costs.

(3)Included in cost of sales.

(4)Excludes $33.9 million of acquired capital expenditures in EIG.

			Nine Months Ended September 30, 2024
			EMG						EIG						Corporate						Total Consolidated
Net Sales			$	1,734,598					$	3,444,980					$	—					$	5,179,578
Cost of sales (1)			1,322,180						2,025,680						—						3,347,860
Selling expense			67,106						377,540						—						444,646
Segment Operating Income			345,312						1,041,760						—						1,387,072
Corporate G&A			—						—						76,491						76,491
Operating Income			345,312						1,041,760						(76,491)						1,310,581
Interest expense			—						—						(90,962)						(90,962)
Other (expense) income, net			—						—						(2,435)						(2,435)
Income before Income Taxes			$	345,312					$	1,041,760					$	(169,888)					$	1,217,184
Depreciation			$	44,802					$	52,553					$	4,338					$	101,693
Amortization			55,925						129,431						—						185,356
Total depreciation and amortization			$	100,727					$	181,984					$	4,338					$	287,049
Research, Development & Engineering costs (2)			$	36,864					$	153,576					$	—					$	190,440
Capital Expenditures			$	27,845					$	36,765					$	10,740					$	75,350

(1)Includes $29.2 million in EMG for Paragon acquisition-related costs.

(2)Included in cost of sales.

X

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 25
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-25

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-22

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147482810/280-10-50-30

+ Details

Name:	us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration